Category: neuroscience retractions

1st retraction for researcher who lost whistleblower lawsuit

microvascular-research

A researcher who was dismissed from Wayne State University — then lost a whistleblower lawsuit against it — has logged his first retraction.

In 2012, after Christian Kreipke was dismissed from Wayne State, he filed a lawsuit, alleging that the institution had defrauded the U.S. government of $169 million in research funding. A judge dismissed the case in 2014, noting Kreipke cited “no specific facts,” and as a public university, Wayne State had immunity as an “arm of the state.”

The university’s president has said Kreipke was fired due to misconduct — not his whistleblowing, according to Courthouse News Service. 

Now, a retraction has appeared for Kreipke in Microvascular Research, citing discrepancies between the original data and what was reported in the paper. 

Here’s the retraction notice: Continue reading 1st retraction for researcher who lost whistleblower lawsuit

Data were “fraudulently obtained” in epilepsy paper, probe finds

brain-research-bulletinA brain research journal has retracted a 2016 study about epilepsy after an institutional investigation determined that some of the data were taken from another published paper.

The retraction notice for the study — which appeared in Brain Research Bulletin — cites an investigation by the scientific integrity committee at Tongji University in Shanghai, China, which concluded the authors had engaged in “unethical publishing behavior.”

Here’s the retraction notice for “Clc-2 knockout attenuated experimental temporal lobe epilepsy in mice by tonic inhibition mediated by GABAA receptors:” Continue reading Data were “fraudulently obtained” in epilepsy paper, probe finds

Amid controversial Sarepta approval decision, FDA head calls for key study retraction

FDAThe head of the U.S. Food and Drug Administration (FDA) has called for the retraction of a study about a drug that the agency itself approved earlier this week, despite senior staff opposing the approval.

On September 19, the FDA okayed eteplirsen to treat Duchenne muscular dystrophy (DMD), a rare genetic disorder that results in muscle degeneration and premature death. Several of its top officials disagreed with the drug’s approval, questioning how beneficial it will be for patients, as Forbes, MedPage Today and others reported.

In a lengthy report Commissioner Robert Califf sent to senior FDA officials on September 16 — that was made public on September 19 — he called for the retraction of a 2013 study published in Annals of Neurology funded by the seller of eteplirsen, which showed beneficial effects of the drug in DMD patients. Califf writes in the report:

Continue reading Amid controversial Sarepta approval decision, FDA head calls for key study retraction

Authors didn’t generate key brain images, probe finds

Frontiers in Human NeuroscienceA neuroscience journal has issued a retraction after discovering some of the paper’s integral images didn’t originate from the authors’ labs.

The retraction notice  — for a study about a condition once known as “water on the brain” — cites an investigation by the journal’s publisher, Frontiers, which determined that the figures were not “duly attributed.” The authors say they agree with the retraction.  

Here’s the retraction notice for “Revisiting hydrocephalus as a model to study brain resilience,” published by Frontiers in Human Neuroscience: Continue reading Authors didn’t generate key brain images, probe finds

Journal blacklists authors for plagiarizing case report about hypersexuality in dementia

Advances in Human BiologyA biology journal has blacklisted authors from publishing their work after finding their case report about a dementia patient with hypersexuality was plagiarized from a previously published report.

The retraction notice, issued by Advances in Human Biology (AIHB) in June, recognizes the case as “scientific misconduct.” The journal launched an investigation after the plagiarism was flagged by the author of the original report, the editor-in-chief of the journal told us. Eventually, the journal retracted the report — and removed it entirely from their website.

Additionally, the journal posted this notice on their site, blacklisting the authors from publishing in AIHB again: Continue reading Journal blacklists authors for plagiarizing case report about hypersexuality in dementia

A headache: Brain paper retracted over author argument

neurochemical researchResearchers have retracted a paper following an argument over who deserves top billing, according to the last author of the paper.

The last author added the authors plan to republish the paper once they work things out.

The work for the paper — about cell death in the aftermath of a brain hemorrhage — was started in one lab at the Department of Neurology at the Affiliated Hospital of Nantong University, and completed in another.

That led to a dispute, reports the retraction notice, issued by Neurochemical Research:

Continue reading A headache: Brain paper retracted over author argument

Neuroscientist in Serbia earns 8th retraction amid investigation

RadenovicA neurobiologist has notched her eight retraction in the midst of an ongoing investigation into her work by her institution, the University of Belgrade in Serbia.

As we reported previously, a mass clean-up by the Archives of Biological Sciences (ABS), the official journal of the Serbian Biological Society resulted in six retractions of papers co-authored by Lidija Radenović. (Radenović served as vice president of the Serbian Biological Society until July 2014.)

In April, we reported that Radenović was about to notch her seventh retraction in Acta Neurologica Scandinavica; that paper has now been pulled, and ABS has retracted another one of her papers.

Here’s the retraction notice by ABS: Continue reading Neuroscientist in Serbia earns 8th retraction amid investigation

You’ve been dupe’d: Nice data — let’s see them again

As we’ve said before, with hundreds of retractions per year, there are simply too many for us to cover individually.

So from time to time we’ll compile a list of retractions that appeared relatively straightforward, just for record-keeping purposes.

Often, these seemingly straightforward retractions involve duplications, in which authors — accidentally or on purpose — republish their own work elsewhere.

Sometimes journals and authors blame this event on “poor communication,” our first example notes:

Continue reading You’ve been dupe’d: Nice data — let’s see them again

4th retraction for neuroscientist sentenced for fraud

Bruce Murdoch
Bruce Murdoch

A Parkinson’s researcher has earned his fourth retraction after receiving a two-year suspended sentence for fraud.

The sentence for Bruce Murdoch, issued on March 31, 2016, came following an investigation by his former employer, the University of Queensland (UQ) in Australia, into 92 papers. Murdoch entered guilty pleas for 17 fraud-related charges, which resulted in the retraction of three papers co-authored by Murdoch and Caroline Barwood, another former UQ Parkinson’s researcher who faced fraud charges (and was granted bail in 2014).

Now, a fourth retraction has appeared for Murdoch in Brain Injury, this time for duplication and failing to obtain consent from his co-authors.

Here’s the retraction notice, issued on July 11: Continue reading 4th retraction for neuroscientist sentenced for fraud

Doctor who blew whistle on defunded study speaks

steve williams
Steve Williams

It’s rare for the U.S. government to revoke grants – but it happened recently, according to a report this week by the Kentucky Center for Investigative Reporting (KyCIR). As the report notes, in March the government revoked $914,000 in funding awarded to Susan Harkema at the University of Louisville in Kentucky, after discovering problems with a study that examined whether the muscle relaxant baclofen helps paralyzed patients move on treadmills. (The university has denied it lost any government funding; a representative of Louisville Public Media, which houses the KyCIR, is standing by the story.) All of this has not been news to Steve Williams, a physician now based at the University of Washington, who has been raising questions about the study for years.

Retraction Watch: What was your role in the study in question, that’s now been defunded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILIRR)?

Steve Williams: I was the study physician who evaluated patients for enrollment.

RW: According to the KyCIR, the study began recruiting patients in 2012. When did you start getting concerned about how it was being conducted? Continue reading Doctor who blew whistle on defunded study speaks